Merve Durhan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Merve Durhan has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Yilmaz Cigremis
Inonu University
8 shared publications - Azibe Yildiz
Department of Histology and Embryology, Faculty of Medicine, Inonu University, Malatya, Turkey
7 shared publications - Onural Ozhan
Department of Pharmacology, Faculty of Medicine, Inonu University, Malatya, Turkey
7 shared publications - Hakan Parlakpinar
Department of Pharmacology, Faculty of Medicine, Inonu University, Malatya, Turkey
6 shared publications - Nigar Vardi
Department of Histology and Embryology, Faculty of Medicine, Inonu University, Malatya, Turkey
5 shared publications - Ahmet Acet
Department of Pharmacology, Faculty of Medicine, Inonu University, Malatya, Turkey
3 shared publications
Latest Publications
- Open Access
- 18 August 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Resveratrol exerts neuroprotective properties by modulating brain SIRT1 gene expression in lipopolysaccharide-induced neuroinflammation in rats
- 18 August 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessResveratrol exerts neuroprotective properties by modulating brain SIRT1 gene expression in lipopolysaccharide-induced neuroinflammation in rats
- Open Access
- 16 June 2026
- Published by Springer Nature in Discover Medicine
- Vol. 3 (1)
Carvacrol attenuates renal ischemia-reperfusion injury in rats via antioxidant and anti-apoptotic mechanisms
- 16 June 2026
- Published by Springer Nature in Discover Medicine
- Vol. 3 (1)
Open AccessCarvacrol attenuates renal ischemia-reperfusion injury in rats via antioxidant and anti-apoptotic mechanisms
- Open Access
- 10 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Evaluation of vinpocetine in an acute doxorubicin-induced cardiotoxicity model in rats
Doxorubicin (DOX) is an effective antineoplastic agent whose clinical use is limited by cardiotoxicity. This study aimed to evaluate the potential protective effects of vinpocetine (VINPO) in an acute DOX-induced cardiotoxicity model in rats. Thirty-two male Wistar albino rats were randomly assigned to four groups: Control, DOX (20 mg/kg, single intraperitoneal dose), VINPO (10 mg/kg for 3 days), and VINPO + DOX. Forty-eight hours after DOX administration, electrocardiography (ECG), heart rate (HR), blood pressure (BP), and oxygen saturation were recorded. Serum troponin-I, creatin kinase (CK), and CK-MB mass levels were measured. Myocardial and vascular tissues were analyzed for malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), and reduced glutathione (GSH). Histopathological and caspase-3 immunohistochemical evaluations were also performed. DOX administration resulted in significant alterations in vascular antioxidant enzyme activities and increased myocardial histopathological injury scores compared with controls. VINPO partially modulated certain oxidative stress parameters, particularly vascular SOD and CAT activities. However, serum cardiac biomarkers, ECG parameters, and caspase-3 immunoreactivity did not differ significantly among groups. Histopathological myocardial injury was not significantly improved in the VINPO + DOX group compared with DOX alone. VINPO demonstrated modest modulatory effects on selected oxidative stress parameters in acute DOX-induced cardiotoxicity. However, these effects were not consistently supported by functional or histopathological findings. Further studies using more severe or longer-term cardiotoxicity models are warranted to clarify its cardioprotective potential.
- 10 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessEvaluation of vinpocetine in an acute doxorubicin-induced cardiotoxicity model in rats
Doxorubicin (DOX) is an effective antineoplastic agent whose clinical use is limited by cardiotoxicity. This study aimed to evaluate the potential protective effects of vinpocetine (VINPO) in an acute DOX-induced cardiotoxicity model in rats. Thirty-two male Wistar albino rats were randomly assigned to four groups: Control, DOX (20 mg/kg, single intraperitoneal dose), VINPO (10 mg/kg for 3 days), and VINPO + DOX. Forty-eight hours after DOX administration, electrocardiography (ECG), heart rate (HR), blood pressure (BP), and oxygen saturation were recorded. Serum troponin-I, creatin kinase (CK), and CK-MB mass levels were measured. Myocardial and vascular tissues were analyzed for malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), and reduced glutathione (GSH). Histopathological and caspase-3 immunohistochemical evaluations were also performed. DOX administration resulted in significant alterations in vascular antioxidant enzyme activities and increased myocardial histopathological injury scores compared with controls. VINPO partially modulated certain oxidative stress parameters, particularly vascular SOD and CAT activities. However, serum cardiac biomarkers, ECG parameters, and caspase-3 immunoreactivity did not differ significantly among groups. Histopathological myocardial injury was not significantly improved in the VINPO + DOX group compared with DOX alone. VINPO demonstrated modest modulatory effects on selected oxidative stress parameters in acute DOX-induced cardiotoxicity. However, these effects were not consistently supported by functional or histopathological findings. Further studies using more severe or longer-term cardiotoxicity models are warranted to clarify its cardioprotective potential.
- 2 April 2026
- Published by Taylor & Francis in Biotechnic & Histochemistry
- p. 1-14
The neuroprotective effects of thalidomide in cerebral ischemia-reperfusion injury induced by bilateral carotid artery occlusion in rats
Cerebral ischemia-reperfusion (I/R) injury is a complex pathophysiological process that occurs after the restoration of blood flow to the brain following a period of ischemia. This can lead to sign...
- 2 April 2026
- Published by Taylor & Francis in Biotechnic & Histochemistry
- p. 1-14
The neuroprotective effects of thalidomide in cerebral ischemia-reperfusion injury induced by bilateral carotid artery occlusion in rats
Cerebral ischemia-reperfusion (I/R) injury is a complex pathophysiological process that occurs after the restoration of blood flow to the brain following a period of ischemia. This can lead to sign...
- Open Access
- 27 March 2026
- Published by Galenos Yayinevi in Medeniyet Medical Journal
- Vol. 41 (1) , 10-23
The Protective Effect of Carvacrol Against Isoproterenol-Induced Cardiotoxicity in Rats
The Protective Effect of Carvacrol Against Isoproterenol-Induced Cardiotoxicity in Rats - Medeniyet Medical Journal
- 27 March 2026
- Published by Galenos Yayinevi in Medeniyet Medical Journal
- Vol. 41 (1) , 10-23
Open AccessThe Protective Effect of Carvacrol Against Isoproterenol-Induced Cardiotoxicity in Rats
The Protective Effect of Carvacrol Against Isoproterenol-Induced Cardiotoxicity in Rats - Medeniyet Medical Journal
- 15 January 2026
- Published by Ataturk Universitesi in Recent Trends in Pharmacology
- Vol. 3 (3) , 75-86
Thalidomide Modulates Oxidative Stress and Tubular Pathology in Renal Ischemia-Reperfusion in a Timing-Dependent Manner
Background: Renal ischemia–reperfusion (IR) drives acute kidney injury through oxidative stress and inflammation. Thalidomide (TD), an immunomodulatory agent, may attenuate IR-related biochemical and structural damage. Methods: Thirty-two female Wistar albino rats were randomized to four groups (n=8): Sham, IR, TD+IR (20 mg/kg i.p. 30 min before ischemia), and IR+TD (20 mg/kg i.p. immediately after 60-min ischemia). All animals underwent right nephrectomy, left renal ischemia (60 min), and 24-h reperfusion. Outcomes included serum blood urea nitrogen (BUN)/creatinine (CR)/albumin; renal malondialdehyde (MDA), glutathione (GSH), superoxide dismutase (SOD), catalase (CAT); and histopathology (tubular dilatation, epithelial shedding, intertubular congestion). Results: IR increased BUN/CR versus Sham, while albumin was unchanged. TD+IR modestly lowered BUN/CR compared with IR, whereas IR+TD did not improve these indices at 24 h. MDA rose with IR and was reduced by TD+IR (vs IR), but not by IR+TD; CAT fell with IR and was highest in IR+TD, while GSH and SOD showed no significant group differences. Histologically, IR produced tubular epithelial shedding, dilatation, and intertubular congestion. TD+IR improved all parameters except epithelial shedding (vs IR), and IR+TD improved all except tubular dilatation; medullary congestion decreased in both TD groups, more prominently with IR+TD. Conclusion: TD confers schedule-dependent renoprotection in renal IR. Pre-ischemic dosing more consistently preserves function and limits lipid peroxidation, whereas post-ischemic dosing better enhances CAT activity and alleviates medullary congestion. These data support TD as a context-dependent adjunct for peri-ischemic kidney protection.
- 15 January 2026
- Published by Ataturk Universitesi in Recent Trends in Pharmacology
- Vol. 3 (3) , 75-86
Thalidomide Modulates Oxidative Stress and Tubular Pathology in Renal Ischemia-Reperfusion in a Timing-Dependent Manner
Background: Renal ischemia–reperfusion (IR) drives acute kidney injury through oxidative stress and inflammation. Thalidomide (TD), an immunomodulatory agent, may attenuate IR-related biochemical and structural damage. Methods: Thirty-two female Wistar albino rats were randomized to four groups (n=8): Sham, IR, TD+IR (20 mg/kg i.p. 30 min before ischemia), and IR+TD (20 mg/kg i.p. immediately after 60-min ischemia). All animals underwent right nephrectomy, left renal ischemia (60 min), and 24-h reperfusion. Outcomes included serum blood urea nitrogen (BUN)/creatinine (CR)/albumin; renal malondialdehyde (MDA), glutathione (GSH), superoxide dismutase (SOD), catalase (CAT); and histopathology (tubular dilatation, epithelial shedding, intertubular congestion). Results: IR increased BUN/CR versus Sham, while albumin was unchanged. TD+IR modestly lowered BUN/CR compared with IR, whereas IR+TD did not improve these indices at 24 h. MDA rose with IR and was reduced by TD+IR (vs IR), but not by IR+TD; CAT fell with IR and was highest in IR+TD, while GSH and SOD showed no significant group differences. Histologically, IR produced tubular epithelial shedding, dilatation, and intertubular congestion. TD+IR improved all parameters except epithelial shedding (vs IR), and IR+TD improved all except tubular dilatation; medullary congestion decreased in both TD groups, more prominently with IR+TD. Conclusion: TD confers schedule-dependent renoprotection in renal IR. Pre-ischemic dosing more consistently preserves function and limits lipid peroxidation, whereas post-ischemic dosing better enhances CAT activity and alleviates medullary congestion. These data support TD as a context-dependent adjunct for peri-ischemic kidney protection.
- Open Access
- 26 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
The effects of apocynin on ciprofloxacin-induced oxidative stress-related cardiotoxicity
Ciprofloxacin (CFX), a fluoroquinolone antibiotic, is known to induce oxidative stress–mediated cardiotoxicity. This study investigates the potential protective and therapeutic effects of apocynin (APO), a selective NADPH oxidase (NOX) inhibitor and potent antioxidant, against CFX-induced myocardial injury in rats. Thirty-two male Wistar albino rats were randomly divided into four groups (n = 8). CFX (25 mg/kg, i.p.) was administered twice daily for one week, while APO (20 mg/kg, i.p.) was given once daily for four days either before or after CFX treatment. Hemodynamic parameters (heart rate, systolic, diastolic, and mean blood pressures) and electrocardiographic (ECG) indices (PR, QRS, and QT intervals) were recorded invasively. Histopathological evaluations assessed myocardial inflammation, cardiomyocyte degeneration, and aortic intima–media thickness. Biochemical analyses of cardiac and aortic tissues included measurements of malondialdehyde (MDA), glutathione (GSH), superoxide dismutase (SOD), and catalase (CAT) levels. CFX administration significantly elevated cardiac MDA by ~ 45% and decreased SOD and CAT activities by ~ 30–35% (p < 0.05) compared with controls. These alterations were markedly attenuated in APO-treated rats, where antioxidant enzyme activities increased by ~ 25–40% and MDA levels were restored toward normal values (p < 0.05 vs. CFX). APO also shortened the QT interval by ~ 15% and improved systolic pressure by ~ 12% compared with the CFX group (p < 0.05). Histopathological findings confirmed reduced myocardial degeneration and inflammatory infiltration in both APO + CFX and CFX + APO groups. APO effectively ameliorated CFX-induced cardiac oxidative injury by inhibiting NOX2-mediated reactive oxygen species formation and restoring antioxidant defense mechanisms, leading to functional improvement in ECG and hemodynamic parameters. These results suggest that targeted NOX inhibition may represent a practical pharmacological approach to reduce fluoroquinolone-associated cardiotoxicity, warranting further translational investigation.
- 26 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessThe effects of apocynin on ciprofloxacin-induced oxidative stress-related cardiotoxicity
Ciprofloxacin (CFX), a fluoroquinolone antibiotic, is known to induce oxidative stress–mediated cardiotoxicity. This study investigates the potential protective and therapeutic effects of apocynin (APO), a selective NADPH oxidase (NOX) inhibitor and potent antioxidant, against CFX-induced myocardial injury in rats. Thirty-two male Wistar albino rats were randomly divided into four groups (n = 8). CFX (25 mg/kg, i.p.) was administered twice daily for one week, while APO (20 mg/kg, i.p.) was given once daily for four days either before or after CFX treatment. Hemodynamic parameters (heart rate, systolic, diastolic, and mean blood pressures) and electrocardiographic (ECG) indices (PR, QRS, and QT intervals) were recorded invasively. Histopathological evaluations assessed myocardial inflammation, cardiomyocyte degeneration, and aortic intima–media thickness. Biochemical analyses of cardiac and aortic tissues included measurements of malondialdehyde (MDA), glutathione (GSH), superoxide dismutase (SOD), and catalase (CAT) levels. CFX administration significantly elevated cardiac MDA by ~ 45% and decreased SOD and CAT activities by ~ 30–35% (p < 0.05) compared with controls. These alterations were markedly attenuated in APO-treated rats, where antioxidant enzyme activities increased by ~ 25–40% and MDA levels were restored toward normal values (p < 0.05 vs. CFX). APO also shortened the QT interval by ~ 15% and improved systolic pressure by ~ 12% compared with the CFX group (p < 0.05). Histopathological findings confirmed reduced myocardial degeneration and inflammatory infiltration in both APO + CFX and CFX + APO groups. APO effectively ameliorated CFX-induced cardiac oxidative injury by inhibiting NOX2-mediated reactive oxygen species formation and restoring antioxidant defense mechanisms, leading to functional improvement in ECG and hemodynamic parameters. These results suggest that targeted NOX inhibition may represent a practical pharmacological approach to reduce fluoroquinolone-associated cardiotoxicity, warranting further translational investigation.
- Open Access
- 5 October 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (10) , 1416
Curcumin Alleviates Doxorubicin-Induced Cardiotoxicity by Modulating Apelin Expression
Background: Doxorubicin (Dox)-induced cardiotoxicity is the most important side effect of the drug and significantly limits its use in susceptible patients. Therefore, preventive measures are required to alleviate the Dox-induced cardiac failure. In this study, curcumin, a strong antioxidant agent, was investigated for its potential protective effect on dox-induced cardiotoxicity with its effect on Apelin expression as a mediator of cardiac function. Methods: Wistar albino rats were equally divided into four groups as Control, DOX, CUR, and CUR+DOX. Dox was administered a single dose of 20 mg/kg bw intraperitoneally while 100 mg/kg bw curcumin was given orally for 14 days before the Dox use. Results: DOX group showed a prolonged QT interval on an electrocardiogram and elevated cardiac troponin levels. In biochemical analyses, decreased Superoxide Dismutase activity and increased Malondialdehyde level and Catalase activity were detected in DOX group. Gene expression of Apelin decreased significantly while NF-κB increased in DOX group. Degenerative changes in histopathology, and increased iNOS and nitrotyrosine immunoreactivity were detected in DOX group. However, no significant changes were observed at reduced Glutathione, TNF-, and IL-1β levels. Curcumin use in Dox-given rats altered most of the disturbed parameters investigated in this study, indicating an alleviating effect on Dox-induced cardiotoxicity. Serum and heart Apelin levels and mRNA expression in heart tissue were detected to significantly increase in CUR+DOX group as compared to DOX group. Furthermore, NF-κB mRNA expression was significantly decreased in heart tissue of CUR+DOX group compared with the DOX group. Conclusions: The results suggest that Apelin acts as an important mediator in Dox cardiotoxicity and may be used as a target for treatment of certain cardiomyopathies. By regulating Apelin expression, curcumin may serve as a potential adjunct in cardioprotective approaches.
- 5 October 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (10) , 1416
Open AccessCurcumin Alleviates Doxorubicin-Induced Cardiotoxicity by Modulating Apelin Expression
Background: Doxorubicin (Dox)-induced cardiotoxicity is the most important side effect of the drug and significantly limits its use in susceptible patients. Therefore, preventive measures are required to alleviate the Dox-induced cardiac failure. In this study, curcumin, a strong antioxidant agent, was investigated for its potential protective effect on dox-induced cardiotoxicity with its effect on Apelin expression as a mediator of cardiac function. Methods: Wistar albino rats were equally divided into four groups as Control, DOX, CUR, and CUR+DOX. Dox was administered a single dose of 20 mg/kg bw intraperitoneally while 100 mg/kg bw curcumin was given orally for 14 days before the Dox use. Results: DOX group showed a prolonged QT interval on an electrocardiogram and elevated cardiac troponin levels. In biochemical analyses, decreased Superoxide Dismutase activity and increased Malondialdehyde level and Catalase activity were detected in DOX group. Gene expression of Apelin decreased significantly while NF-κB increased in DOX group. Degenerative changes in histopathology, and increased iNOS and nitrotyrosine immunoreactivity were detected in DOX group. However, no significant changes were observed at reduced Glutathione, TNF-, and IL-1β levels. Curcumin use in Dox-given rats altered most of the disturbed parameters investigated in this study, indicating an alleviating effect on Dox-induced cardiotoxicity. Serum and heart Apelin levels and mRNA expression in heart tissue were detected to significantly increase in CUR+DOX group as compared to DOX group. Furthermore, NF-κB mRNA expression was significantly decreased in heart tissue of CUR+DOX group compared with the DOX group. Conclusions: The results suggest that Apelin acts as an important mediator in Dox cardiotoxicity and may be used as a target for treatment of certain cardiomyopathies. By regulating Apelin expression, curcumin may serve as a potential adjunct in cardioprotective approaches.